Skip to main content

stock

ENVB · Enveric Biosciences, Inc.

What Enveric Biosciences, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live ENVB price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ENVB.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
4,475,884 as of 2026-08-12 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
20.7%
Operating
—
Net
—

Returns

ROE
150.2%
ROA
135.8%

Health

Current ratio
10.2x
Debt/equity
—

Deep value

NCAV
—
NCAV per share
—
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30——-$3.03M-$3.03M
10-Q filed 2026-08-14
2026-03-31——-$1.63M-$1.63M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31——-$2.19M$18.68M
DEF 14A filed 2026-04-14
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30——-$1.87M-$1.87M
10-Q filed 2025-11-14
2025-06-30——-$2.52M-$2.52M
10-Q filed 2026-08-14
2025-03-31——-$2.19M-$2.18M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31——-$3.17M$16.02M
DEF 14A filed 2026-04-14
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30——-$2.08M-$2.08M
10-Q filed 2025-11-14
Assets
$8.94M
Equity
$8.08M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$8.77M$12.10M—
2024-12-31—-$9.63M$9.60M—
2023-12-31—-$16.45M$17.50M-$14.10M
2022-12-31—-$27.42M-$18.47M-$17.73M
2021-12-31—-$64.62M-$48.98M-$11.65M
2020-12-31—-$5.62M-$6.86M—
2019-12-31$39.91M-$2.30M-$2.41M—
2018-12-31$43.00M-$7.15M-$16.90M—
2017-12-31$48.59M-$10.90M-$9.07M—
2016-12-31$36.15M-$5.38M-$2.78M—

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

News

Stories that named ENVB, and the market events around them.

Sign in to see this

Board

The ENVB board could not be loaded.

Retry the ENVB board

nakagai

Signals on ENVB come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ENVB board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Enveric Biosciences, Inc. (ENVB): SEC filings, financials and insider trades · Nakagai